Skip to main content
. 2020 Nov 21;8(2):160–170. doi: 10.1093/nop/npaa078

Table 2.

Complaints Scores (Total, Memory, Attention, Executive) Compared Between Patient Groups With Different Tumor Etiology or Treatment Characteristics

Complaints scores Type of tumor (median [IQR])
Meningioma (n = 8) Glioma (n = 34) Other* (n = 5) Statistics
Total 44.5 (30.3) 24.5 (30) 28 (38.5) χ 2(2) = 5.052, P = .080
Memory 46 (32.8) 16.5 (45.8) 20 (36) χ 2(2) = 5.552, P = .062
Attention 54 (35.8) 31.5 (33.8) 43 (32) χ 2(2) = 6.472, P = .039
Executive 35 (34.5) 22.5 (25.3) 17 (46) χ 2(2) = 2.709, P = .258
Complaints scores Number of treatments (median [IQR])
1 (n = 21) 2 (n = 7) 3 (n = 19) Statistics
Total 28 (40) 28 (24) 25 (30) χ 2(2) = .832, P = .660
Memory 22 (36.5) 20 (39) 22 (34) χ 2(2) = 1.194, P = .550
Attention 43 (42.5) 33 (22) 30 (20) χ 2(2) = 4.812, P = .090
Executive 23 (39.5) 17 (25) 22 (28) χ 2(2) = .129, P = .938
Complaints scores Epilepsy (median [IQR])
Absence (n = 20) Presence (n = 27) Statistics
Total 28 (29) 27.5 (33.3) U = 268.5, z = −.032, P = .974
Memory 20 (37) 22 (39.8) U = 254, z = −.035, P = .730
Attention 37 (35) 33 (25) U = 242.5, z = −.592, P = .554
Executive 22 (26) 23.5 (28.8) U = 261.5, z = −.183, P = .855

Abbreviations: IQR, interquartile range; n, number of patients.

*Note: These patients were diagnosed with: hemangioblastoma, subependymoma, medulloblastoma, lymphoma, or cerebral metastases.